Latest Kidney Cancer News
Kidney Cancer News elsewhere on the Web
Ami Umesh Badami, MD, discusses clinical research that has informed treatment selection in the second-line clear cell renal cell carcinoma setting.
Thomas Westbrook, MD, discusses the non–clear cell renal cell carcinoma research that informs his clinical practice.
Subcutaneous Opdivo improves cancer care by offering faster, accessible therapy, reducing time toxicity and expanding patient access, according to experts.
Recently, as the number of cancer patients has increased, much research is being conducted for efficient treatment, including the use of artificial intelligence in genitourinary pathology. Recent research has focused largely on the classification of renal cell carcinoma subtypes. Nonetheless, ...
Leveraging novel agents, innovative clinical trial designs, and correlative studies may improve the treatment of patients with kidney cancer.
Updated overall survival data from KEYNOTE-564 showed adjuvant pembrolizumab benefits in clear cell renal cell carcinoma, but some patients remain unresponsive.
Alan Tan, MD, discusses the IO-based combination therapies that are available for the treatment of patients with RCC.
Safety data from the phase 2 LITESPARK-003 trial evaluating belzutifan/cabozantinib in renal cell carcinoma show no treatment-related deaths.
Three recent panel discussions on renal cell carcinoma (RCC) treatment strategies from GU Oncology Now emphasized the evolving role of biomarkers, combination...
The underrepresentation of Black patients in past clinical studies assessing advanced renal cell carcinoma (aRCC) therapies means that researchers are ...
No results found.
Articles from Kidney Cancer UK
No results found.
No results found.